Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul 29;14(7):e242689.
doi: 10.1136/bcr-2021-242689.

Maple syrup urine disease associated with nephrotic syndrome in a Filipino child

Ebner Bon G Maceda  1   2 , Michelle E Abadingo  3   4 , Cheryll J Magbanua-Calalo  3   4 , Melissa A Dator  5 , Lourdes Paula R Resontoc  5 , Leniza De Castro-Hamoy  3   2 , Mary Ann R Abacan  3   2 , Mary Anne D Chiong  3   2   6 , Sylvia C Estrada  3   2
Affiliations
Case Reports

Maple syrup urine disease associated with nephrotic syndrome in a Filipino child

Ebner Bon G Maceda et al. BMJ Case Rep. .

Abstract

A 22-month-old female child with maple syrup urine disease (MSUD) presented with generalised oedema. Diagnostic evaluation revealed nephrotic range proteinuria, hypoalbuminaemia and dyslipidaemia supporting the diagnosis of nephrotic syndrome (NS). Diet, being at the core of the management plan for both MSUD and NS, necessitated regular monitoring and evaluation via dried blood spot collection of leucine. The opposing requirement for total protein for both disorders (that is protein restriction in MSUD and protein supplementation in NS) prompted a careful balancing act of the dietary management. The monitoring, which revealed normal leucine levels on multiple determinations, allowed an eventual increase in dietary protein and daily administration of albumin to address the NS. Dietary protein increase, both in total protein (3.5 g/kg/day) and natural protein (1 g/kg/day) levels, was instituted. It was observed that NS does not trigger leucinosis and allowed easing of protein restriction in MSUD.

Keywords: genetics; medical management; paediatrics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Blackburn PR, Gass JM, Vairo FPE, Pinto e Vairo F, et al. . Maple syrup urine disease: mechanisms and management. Appl Clin Genet 2017;10:57–66. 10.2147/TACG.S125962 - DOI - PMC - PubMed
    1. Yunus ZM, Kamaludin DA, Mamat M, et al. . Clinical and biochemical profiles of maple syrup urine disease in Malaysian children. JIMD Rep 2012;5:99–107. 10.1007/8904_2011_105 - DOI - PMC - PubMed
    1. Lee JY, Chiong MA, Estrada SC, et al. . Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients. J Inherit Metab Dis 2008;31 Suppl 2:281–5. 10.1007/s10545-008-0859-0 - DOI - PubMed
    1. Chuang DT, Shih VE. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill, 2001: 1971–2006.
    1. Prevalence of newborn screening disorders. Available: https://www.newbornscreening.ph/images/stories/ResourcesPrevalence/preva... [Accessed 5 Feb 2021].

Publication types